Probert CS - Search Results

1

Evidence for the clinical use of infliximab in Crohn's disease.

Turner SM, Probert CS. Turner SM, et al. Among authors: probert cs. Rom J Gastroenterol. 2003 Mar;12(1):2-5. Rom J Gastroenterol. 2003. PMID: 12673372 No abstract available.

2

Parenteral nutrition via an arteriovenous bypass graft.

Turner SM, Probert CS, Lear P. Turner SM, et al. Among authors: probert cs. Gut. 2003 Aug;52(8):1218. doi: 10.1136/gut.52.8.1218. Gut. 2003. PMID: 12865286 Free PMC article. No abstract available.

3

Intestinal alpha beta T cells differentiate and rearrange antigen receptor genes in situ in the human infant.

Williams AM, Bland PW, Phillips AC, Turner S, Brooklyn T, Shaya G, Spicer RD, Probert CS. Williams AM, et al. Among authors: probert cs. J Immunol. 2004 Dec 15;173(12):7190-9. doi: 10.4049/jimmunol.173.12.7190. J Immunol. 2004. PMID: 15585840

4

Basiliximab and infliximab for the treatment of steroid-refractory Crohn's disease.

Price M, Probert CS, Creed T. Price M, et al. Among authors: probert cs. Am J Gastroenterol. 2008 Oct;103(10):2665. doi: 10.1111/j.1572-0241.2008.02074_14.x. Am J Gastroenterol. 2008. PMID: 18855871 No abstract available.

5

Early use of azathioprine in Crohn's disease.

Hawthorne AB, Probert CS, Sanderson JD. Hawthorne AB, et al. Among authors: probert cs. Gastroenterology. 2014 Mar;146(3):865-6. doi: 10.1053/j.gastro.2013.10.072. Epub 2014 Jan 24. Gastroenterology. 2014. PMID: 24468182 No abstract available.

6

Infliximab use in Crohn's disease: impact on health care resources in the UK.

Jewell DP, Satsangi J, Lobo A, Probert C, Forbes A, Ghosh S, Shaffer J, Frenz M, Drummond H, Troy G, Turner S, Younge L, Evans L, Moosa M, Rodgers-Gray B, Buchan S. Jewell DP, et al. Eur J Gastroenterol Hepatol. 2005 Oct;17(10):1047-52. doi: 10.1097/00042737-200510000-00007. Eur J Gastroenterol Hepatol. 2005. PMID: 16148549

7

Refractory coeliac disease: remission with infliximab and immunomodulators.

Turner SM, Moorghen M, Probert CS. Turner SM, et al. Among authors: probert cs. Eur J Gastroenterol Hepatol. 2005 Jun;17(6):667-9. doi: 10.1097/00042737-200506000-00012. Eur J Gastroenterol Hepatol. 2005. PMID: 15879730 Review.

8

New insights on fibrosis in Crohn's disease.

Bailey JR, Whiting CV, Tarlton JF, Bland PW, Probert CS. Bailey JR, et al. Among authors: probert cs. Expert Rev Gastroenterol Hepatol. 2013 Aug;7(6):497-9. doi: 10.1586/17474124.2013.814931. Expert Rev Gastroenterol Hepatol. 2013. PMID: 23984996 No abstract available.

9

Patient's assessment of an information booklet on Crohn's disease written by a patient.

Probert CS, Godber D, Calcraft B, Mayberry JF. Probert CS, et al. Ital J Gastroenterol. 1991 Jun;23(5):9-43. Ital J Gastroenterol. 1991. PMID: 1742512

10

Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment.

Parker R, Dixit A, Fraser A, Creed TJ, Probert CS. Parker R, et al. Among authors: probert cs. Postgrad Med J. 2010 Apr;86(1014):208-11. doi: 10.1136/pgmj.2009.085787. Postgrad Med J. 2010. PMID: 20354043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters